To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATAD2BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
168 supporting clones for gene ATAD2B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK094821 brain .a 1 to 2066 2 to 2067   tiling clone, available from FLJ,   2067/2067
(100 %)
2 diff
(100.0 %id)
DA208859 brain .a 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA802832 brain .a 49 to 609 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BG388211 embryonal carcinoma, cell line, testis .a 50 to 772 1 to 719   available from MGC,   719/720
(99 %)
11 diff
(98.5 %id)
NM_017552.1   .a 50 to 8107 1 to 8058 exact RefSeq,   8058/8061
(99 %)
5 diff
(100.0 %id)
DA760086   .a 52 to 528 2 to 478   capped   477/477
(100 %)
3 diff
(99.4 %id)
TI_2194698616   .a 53 to 1019 86 to 1047       962/1240
(77 %)
17 diff
(98.7 %id)
TI_2194698737   .a 53 to 713 675 to 15       661/1278
(51 %)
0 diff
(100 %id)
TI_2194698840   .a 53 to 1123 88 to 1147       1060/1305
(81 %)
23 diff
(98.3 %id)
TI_2194699277   .a 53 to 1121 83 to 1140       1058/1265
(83 %)
23 diff
(98.2 %id)
DR001456 fetal brain .a 65 to 825 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
TI_2194698736   .a 74 to 1217 1146 to 13       1134/1299
(87 %)
19 diff
(98.6 %id)
DB012741 esophageal, tumor tissue .a 201 to 753 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AW750646 colon_normal .a 559 to 759 38 to 248       210/257
(81 %)
13 diff
(95.0 %id)
AA508057 Prostate .a 631 to 948 326 to 10       317/326
(97 %)
1 diff
(99.7 %id)
TI_2194698748   .a 663 to 1826 1 to 1158       1158/1324
(87 %)
21 diff
(98.5 %id)
AA713595 germinal center B cell .a 803 to 1223 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
AA912991 pooled .a 834 to 1244 423 to 13       411/423
(97 %)
2 diff
(99.6 %id)
DW441915 Liver .a 892 to 1088 17 to 213       197/236
(83 %)
11 diff
(95.4 %id)
AW853071 colon .a 1050 to 1534 491 to 8       484/491
(98 %)
6 diff
(98.8 %id)
TI_2194698739   .a 1058 to 2162 17 to 1110   tiling clone,   1094/1295
(84 %)
15 diff
(98.9 %id)
CV318991 marrow .a 1824 to 2018 9 to 202       194/223
(86 %)
4 diff
(98.3 %id)
AK131301   .a 1860 to 3572 1 to 1713   tiling clone, available from FLJ,   1713/1713
(100 %)
0 diff
(100 %id)
DA614704   .a 1861 to 2403 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BQ365716 placenta_normal .a 2455 to 2946 23 to 514       492/518
(94 %)
16 diff
(97.0 %id)
BF085638 placenta_normal .a 2469 to 2952 33 to 515       487/520
(93 %)
10 diff
(98.1 %id)
BQ365719 placenta_normal .a 2469 to 2959 25 to 515       496/518
(95 %)
17 diff
(96.8 %id)
BQ365714 placenta_normal .a 2473 to 2929 25 to 481       459/481
(95 %)
9 diff
(98.2 %id)
DA768177 brain .a 2636 to 3145 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
CN357459 embryonic stem cells, DMSO-treated H9 cellline .a 2724 to 3191 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
DB320149   .a 3015 to 3572 558 to 1       558/558
(100 %)
0 diff
(100 %id)
AW183181 pooled .a 3260 to 3813 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
T64079 lung .a 3323 to 3480 1 to 160       160/167
(95 %)
5 diff
(97.1 %id)
TI_2194698730   .a 3357 to 4420 1058 to 4   tiling clone,   1055/1271
(83 %)
10 diff
(99.3 %id)
T64001 lung .a 3520 to 3813 297 to 1       297/297
(100 %)
6 diff
(98.0 %id)
AI821334 lung .a 3538 to 3813 276 to 1       276/276
(100 %)
0 diff
(100 %id)
AI684152 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3538 to 3814 277 to 1       277/277
(100 %)
0 diff
(100 %id)
CV573107 cornea, eye .a 3594 to 4186 1 to 593       593/593
(100 %)
0 diff
(100 %id)
TI_2194698744   .a 3689 to 4781 4 to 1086       1083/1292
(83 %)
15 diff
(98.9 %id)
AW948890 prostate_tumor .a 3740 to 3991 257 to 5     Submitted on the opposite strand 253/257
(98 %)
0 diff
(100 %id)
CA394347 eye, RPE/choroid .a 3805 to 4496 1 to 692       692/692
(100 %)
0 diff
(100 %id)
TI_2194698729   .a 3806 to 4909 1100 to 5       1096/1272
(86 %)
11 diff
(99.2 %id)
BF999690 placenta_normal .a 3841 to 4232 411 to 21       391/411
(95 %)
0 diff
(100 %id)
BF917782 uterus_tumor .a 3861 to 4018 158 to 1     Submitted on the opposite strand 158/158
(100 %)
1 diff
(99.4 %id)
TI_2194698745   .a 3981 to 5070 7 to 1087       1081/1282
(84 %)
20 diff
(98.5 %id)
BX479082   .a 3989 to 4613 1 to 625       625/625
(100 %)
0 diff
(100 %id)
TI_2194698628   .a 4061 to 5085 1133 to 117   tiling clone,   1017/1257
(80 %)
10 diff
(99.3 %id)
TI_2194699657   .a 4103 to 5085 1085 to 113       973/1265
(76 %)
9 diff
(99.3 %id)
BF062035 pooled germ cell tumors .a 4331 to 4715 385 to 1       385/385
(100 %)
12 diff
(96.9 %id)
DB147416 thymus .a 4457 to 5022 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AW103447 ovary, tumor, 5 pooled (see description) .a 4486 to 4963 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AI073544   .a 4487 to 4964 481 to 4       478/481
(99 %)
0 diff
(100 %id)
DB525624 testis .a 4518 to 4963 1 to 446     Submitted on the opposite strand 446/446
(100 %)
1 diff
(99.8 %id)
TI_2194698746   .a 4549 to 5085 1 to 535       535/1311
(40 %)
6 diff
(99.6 %id)
AI807956 pooled .a 4696 to 4948 296 to 43   AAA   254/271
(93 %)
0 diff
(100 %id)
CN357463 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5028 to 5689 1 to 662       662/662
(100 %)
5 diff
(99.3 %id)
BQ228516 embryonal carcinoma, cell line, testis .a 5070 to 5878 1 to 823   tiling clone,   823/825
(99 %)
22 diff
(97.4 %id)
DA619158   .a 5112 to 5659 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AW206687   .a 5131 to 5568 453 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 438/438
(100 %)
1 diff
(99.8 %id)
CN357460 embryonic stem cells, cell lines H1, H7, andH9 .a 5188 to 5857 1 to 668       668/668
(100 %)
3 diff
(99.6 %id)
AF038204 brain .a 5368 to 7023 1 to 1656   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1656/1656
(100 %)
2 diff
(99.9 %id)
Z46217 brain, total brain .a 5368 to 5643 1 to 276       276/276
(100 %)
0 diff
(100 %id)
T77672 whole brain .a 5396 to 5569 1 to 174     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 174/174
(100 %)
0 diff
(100 %id)
DA020938   .a 5604 to 6162 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
CN357462 embryonic stem cells, DMSO-treated H9 cellline .a 5626 to 6062 1 to 437   tiling clone,   437/437
(100 %)
1 diff
(99.8 %id)
AA720611 germinal center B cell .a 5676 to 6077 408 to 7       402/408
(98 %)
0 diff
(100 %id)
DB253221 uterus .a 5705 to 6268 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
CA336992 posterior rhombomeres 5-8 (4 pooled) .a 5843 to 6078 1 to 236   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 236/236
(100 %)
0 diff
(100 %id)
BM718545 eye, fetal eye .a 5883 to 6416 1 to 534   tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
AV745166 Pituitary .a 5916 to 6553 1 to 639       639/696
(91 %)
31 diff
(95.6 %id)
DA732612   .a 6068 to 6679 2 to 617   capped   616/616
(100 %)
11 diff
(98.3 %id)
DB104915 thymus .a 6297 to 6850 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
FN158541 breast carcinoma .a 6593 to 6708 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
R38390 whole brain .a 6892 to 7023 148 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 130/130
(100 %)
7 diff
(94.7 %id)
DB364183   .a 7769 to 8101 333 to 1   tiling clone,   333/333
(100 %)
2 diff
(99.4 %id)
BC171846 Brain, cerebral cortex, PCR rescued clones .b 1 to 5102 1 to 5102 Q207R tiling clone,   5102/5102
(100 %)
1 diff
(100.0 %id)
TI_2194698740   .b 1662 to 2836 16 to 1160       1122/1262
(88 %)
33 diff
(97.4 %id)
TI_2194698732   .b 2069 to 3231 1150 to 1       1152/1290
(89 %)
18 diff
(98.7 %id)
TI_2194698741   .b 2164 to 3151 10 to 995       986/1249
(78 %)
9 diff
(99.3 %id)
TI_2194698731   .b 2669 to 3879 1204 to 9       1196/1289
(92 %)
8 diff
(99.4 %id)
TI_2194698742   .b 2732 to 3928 5 to 1192       1188/1330
(89 %)
22 diff
(98.4 %id)
BX488730   .b 2904 to 3417 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
TI_2194698743   .b 3242 to 4357 11 to 1112       1102/1237
(89 %)
27 diff
(97.9 %id)
AB033066 brain .c 1 to 5579 1 to 5579 exact tiling clone, available from KIAA,   5579/5579
(100 %)
0 diff
(100 %id)
DB100984 thymus .c 3490 to 4015 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
AU118625 whole embryo, mainly head .c 4109 to 4901 2 to 793   capped   792/803
(98 %)
12 diff
(98.6 %id)
BE618122 eye, retinoblastoma .c 4139 to 4728 1 to 586       586/587
(99 %)
7 diff
(98.9 %id)
R51886 whole brain .c 4175 to 4507 360 to 20   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 341/343
(99 %)
11 diff
(96.8 %id)
BG546469 lung .c 4211 to 4931 1 to 719       719/721
(99 %)
12 diff
(98.4 %id)
CN357457 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4285 to 5023 1 to 741       741/741
(100 %)
3 diff
(99.6 %id)
R40369 whole brain .c 4329 to 4507 198 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 181/181
(100 %)
2 diff
(98.9 %id)
AA036721 uterus .c 4342 to 4686 1 to 346       346/346
(100 %)
1 diff
(99.8 %id)
AA128113 uterus .c 4342 to 4635 1 to 294       294/302
(97 %)
1 diff
(99.7 %id)
AA406448 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4342 to 4785 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
BF245614 brain, glioblastoma .c 4398 to 4565 1 to 170       170/170
(100 %)
3 diff
(98.3 %id)
CK023849 brain/CNS, Human Brain - Cerebellar Cortex .c 4632 to 5251 1 to 619       619/623
(99 %)
6 diff
(99.1 %id)
BG573940 placenta .c 4676 to 5397 1 to 719       719/727
(98 %)
20 diff
(97.3 %id)
BM172074 placenta .c 4676 to 5238 1 to 562       562/563
(99 %)
6 diff
(99.0 %id)
BU624210 cell lines, Enchondroma .c 4789 to 5579 810 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 792/797
(99 %)
4 diff
(99.5 %id)
TI_151760616   .c 4790 to 5585 877 to 90   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 788/941
(83 %)
15 diff
(98.5 %id)
TI_149292312   .c 4822 to 5585 839 to 80   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 760/886
(85 %)
14 diff
(98.5 %id)
TI_149292310   .c 4826 to 5585 835 to 76   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 760/920
(82 %)
3 diff
(99.7 %id)
BM974506 lung .c 4826 to 5585 772 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 760/771
(98 %)
3 diff
(99.7 %id)
BE618708 eye, retinoblastoma .c 4884 to 5504 675 to 30       646/938
(68 %)
0 diff
(100 %id)
BM974508 lung .c 4910 to 5585 688 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 676/676
(100 %)
3 diff
(99.6 %id)
DB356772 whole embryo, mainly head .c 5008 to 5585 580 to 1       580/580
(100 %)
19 diff
(96.8 %id)
BF591253 colon, colon tumor, RER+ .c 5024 to 5567 543 to 1       543/543
(100 %)
2 diff
(99.7 %id)
AI830496 Kidney .c 5030 to 5576 547 to 1       547/547
(100 %)
0 diff
(100 %id)
AW977789   .c 5065 to 5578 514 to 1     Submitted on the opposite strand 514/632
(81 %)
0 diff
(100 %id)
AW571686 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 5103 to 5582 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AA126920 uterus .c 5104 to 5586 491 to 2       490/495
(98 %)
0 diff
(100 %id)
AW298409   .c 5114 to 5586 489 to 17       473/489
(96 %)
0 diff
(100 %id)
CN357458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5117 to 5584 1 to 468       468/470
(99 %)
1 diff
(99.8 %id)
AI275463 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5119 to 5586 470 to 4       467/470
(99 %)
0 diff
(100 %id)
BE220244 carcinoid, lung .c 5125 to 5586 463 to 2       462/463
(99 %)
0 diff
(100 %id)
AA767863 germinal center B cell .c 5135 to 5586 459 to 9       451/459
(98 %)
0 diff
(100 %id)
DB326239.
matches multiple genes
brain .c 5140 to 5579 440 to 1     also hits gene mamiya 440/540
(81 %)
3 diff
(99.5 %id)
AI160602 placenta .c 5148 to 5580 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AI217929   .c 5150 to 5586 451 to 15       437/451
(96 %)
0 diff
(100 %id)
AI805920 pooled .c 5151 to 5586 443 to 8       436/443
(98 %)
0 diff
(100 %id)
DB514864 testis .c 5154 to 5585 1 to 436     Submitted on the opposite strand 436/436
(100 %)
22 diff
(95.0 %id)
AA714910 Ewing's sarcoma .c 5154 to 5545 30 to 421       392/421
(93 %)
7 diff
(98.4 %id)
AA057360 uterus .c 5158 to 5585 429 to 1       429/432
(99 %)
3 diff
(99.4 %id)
AA410403 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5170 to 5585 416 to 1       416/417
(99 %)
0 diff
(100 %id)
AA810578 germinal center B cell .c 5179 to 5424 246 to 1       246/246
(100 %)
0 diff
(100 %id)
FN147347 breast carcinoma .c 5212 to 5288 76 to 1     Submitted on the opposite strand 76/85
(89 %)
1 diff
(98.9 %id)
FN047988 breast carcinoma .c 5482 to 5579 1 to 98       98/98
(100 %)
0 diff
(100 %id)
FN074387 breast carcinoma .c 5482 to 5579 1 to 96       96/96
(100 %)
2 diff
(98.0 %id)
BI497091 cochlea, ear .c 5553 to 6008 8 to 463   tiling clone,   456/463
(98 %)
6 diff
(98.8 %id)
DB342175 thymus .c 5670 to 6160 491 to 1   tiling clone,   491/491
(100 %)
0 diff
(100 %id)
AK125718 testis .d 1 to 3764 2 to 3765 exact tiling clone, available from FLJ,   3765/3765
(100 %)
0 diff
(100 %id)
DB019838 testis .d 1 to 533 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB335739 testis .d 3575 to 3764 190 to 2       189/190
(99 %)
0 diff
(100 %id)
BC037408 Testis, embryonal carcinoma .e 1 to 1410 12 to 1421 Q207R R371K tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1410/1419
(99 %)
3 diff
(99.8 %id)
AW182580 pooled .e 761 to 1238 490 to 13       478/490
(97 %)
1 diff
(99.8 %id)
DB234593 trachea .f-u 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
AA632094 breast .f-u 241 to 639 400 to 2       399/400
(99 %)
0 diff
(100 %id)
DA510106 brain .f-u 268 to 824 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB153211 thymus .f-u 322 to 901 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BG288406 bladder, transitional cell papilloma, cell line .f-u 454 to 1054 1 to 601       601/605
(99 %)
6 diff
(99.1 %id)
BQ640500 eye, retina .f-u 571 to 1072 1 to 502   tiling clone,   502/502
(100 %)
0 diff
(100 %id)
AI417302 anaplastic oligodendroglioma, brain .f-u 762 to 1243 482 to 1   tiling clone,   482/482
(100 %)
0 diff
(100 %id)
CD518220 White Matter .g 1 to 854 1 to 859 exact tiling clone,   859/874
(98 %)
13 diff
(98.6 %id)
CB988926 Human Placenta, placenta .h-u 1 to 750 27 to 782 Q123P R124E L132F L133A K135S ... tiling clone,   757/789
(95 %)
13 diff
(98.4 %id)
DB084110 testis .i 1 to 558 2 to 559 exact tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DB460182 testis .i 29 to 489 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
R77197 placenta .j 1 to 538 1 to 541   tiling clone,   541/543
(99 %)
26 diff
(95.3 %id)
R80484 placenta .j 1 to 422 1 to 429   tiling clone,   429/434
(98 %)
24 diff
(94.5 %id)
R77182 placenta .j 2 to 431 1 to 440   tiling clone,   440/447
(98 %)
13 diff
(97.1 %id)
BQ024452 placenta .j 453 to 908 456 to 1   tiling clone,   456/456
(100 %)
2 diff
(99.6 %id)
R80380 placenta .j 533 to 879 348 to 1       348/357
(97 %)
2 diff
(99.5 %id)
DB098017 testis .j 857 to 1272 2 to 419 exact tiling clone, capped   418/418
(100 %)
3 diff
(99.3 %id)
DB449668 testis .k 1 to 470 1 to 469   tiling clone,   469/469
(100 %)
3 diff
(99.4 %id)
CN357461 embryonic stem cells, cell lines H1, H7, andH9 .k 354 to 923 1 to 570   tiling clone,   570/570
(100 %)
0 diff
(100 %id)
FN175672 breast carcinoma .k 660 to 748 1 to 89       89/93
(95 %)
5 diff
(94.7 %id)
DB231712 trachea .k 665 to 1230 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DB078323 testis .l 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
DB245048 uterus, tumor tissue .m-u 1 to 563 2 to 566   tiling clone, capped   565/565
(100 %)
4 diff
(99.3 %id)
BJ993247 hepatoblastoma .m-u 251 to 850 1 to 600   tiling clone,   600/600
(100 %)
2 diff
(99.7 %id)
DA046517 bladder .m-u 559 to 1129 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
GD135827   .m-u 643 to 853 1 to 212       212/212
(100 %)
4 diff
(98.2 %id)
BG428584 Kidney .m-u 1016 to 1794 1 to 768 exact available from MGC,   768/770
(99 %)
30 diff
(96.2 %id)
BC071781 Kidney .m-u 1017 to 2372 1 to 1357 exact tiling clone, available from MGC, AAA   1357/1357
(100 %)
4 diff
(99.8 %id)
BJ993248 hepatoblastoma .m-u 1819 to 2298 480 to 1   tiling clone,   480/480
(100 %)
9 diff
(98.2 %id)
DB350684 uterus, tumor tissue .m-u 1874 to 2388 519 to 3   tiling clone,   517/519
(99 %)
0 diff
(100 %id)
AK023705 placenta .n 1 to 1669 2 to 1670 exact tiling clone, available from FLJ,   1670/1674
(99 %)
3 diff
(99.9 %id)
AU139758 placenta .n 1 to 630 2 to 631 exact capped   630/631
(99 %)
7 diff
(98.9 %id)
BP432584   .n 63 to 406 1 to 344 exact tiling clone,   344/344
(100 %)
5 diff
(98.6 %id)
BF361150 ovary .n 645 to 1185 547 to 5       543/554
(98 %)
0 diff
(100 %id)
DB113047 thymus .n 785 to 1364 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
AU158161 placenta .n 1166 to 1669 502 to 5       498/588
(84 %)
0 diff
(100 %id)
BQ343871 nervous_tumor .n 1206 to 1520 327 to 13       315/331
(95 %)
0 diff
(100 %id)
BE221020 malignant melanoma, metastatic to lymphnode, skin .n 1436 to 1669 239 to 7   tiling clone,   233/239
(97 %)
0 diff
(100 %id)
DA122695 cerebellum .n 1517 to 2053 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
FN054320 breast carcinoma .n 1905 to 2019 115 to 1     Submitted on the opposite strand 115/115
(100 %)
0 diff
(100 %id)
DB067619 testis .o 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
DB030525 testis .p 1 to 520 2 to 522 exact tiling clone, capped Suspected internal deletion 521/541
(96 %)
3 diff
(99.5 %id)
AA748005 germinal center B cell .q-u 1 to 359 369 to 11 exact tiling clone, AAA   359/359
(100 %)
0 diff
(100 %id)
AW996842 breast_normal Gene ATAD2B, variant not shown         Suspected internal deletion, this clone was ignored    
BU569940 testis Gene ATAD2B, variant not shown         This clone was ignored    
DB328810 placenta Gene ATAD2B, variant not shown         This clone was ignored    
DA853401 placenta Gene ATAD2B, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h-u, .i, .j, .k, .l, .m-u, .n, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C